Monsanto dominated the battle over first-generation biotech seeds and traits—those largely focused on input traits such as" />
IHS Chemical Week

Chemical Week Magazine :: Viewpoint

Monsanto Yields

8:08 AM MDT | April 9, 2010

So Monsanto’s seeds and trait sales and earnings won’t grow to the sky forever. Monsanto has had an impressive run since its 2000 spin off from Pharmacia, with profits and its market capitalization up more than fivefold. The mid-2008 commodity and financial bust pushed the stock off its peak, but a fierce customer push back on pricing now has the company ratcheting down earnings expectations. Monsanto dominated the battle over first-generation biotech seeds and traits—those largely focused on input traits such as...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa